Carebastine, an H1-receptor antagonist, suppresses the expression of macrophage migration inhibitory factor

被引：4

作者：

Zhao, Y. ^{[1
]}

Makino, T. ^{[2
]}

Honda, A. ^{[2
]}

Shimizu, H. ^{[1
]}

Yamagishi, S. ^{[3
]}

Shimizu, T. ^{[2
]}

机构：

[1] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 060, Japan

[2] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Dermatol, Toyama 9300194, Japan

[3] Kurume Univ, Sch Med, Dept Internal Med 3, Kurume, Fukuoka 830, Japan

来源：

CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2008年 / 33卷 / 06期

关键词：

D O I：

10.1111/j.1365-2230.2008.02843.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：785 / 787

页数：4

共 5 条

[1] Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults [J].

Kalis, B .

DRUGS, 1996, 52 :30-34

[2] Ebastine inhibits T cell migration, production of Th2-type cytokines and proinflammatory cytokines [J].

Nori, M ;

Iwata, S ;

Munakata, Y ;

Kobayashi, H ;

Kobayashi, S ;

Umezawa, Y ;

Hosono, O ;

Kawasaki, H ;

Dang, NH ;

Tanaka, H ;

Shiohara, T ;

Morimoto, C .

CLINICAL AND EXPERIMENTAL ALLERGY, 2003, 33 (11) :1544-1554

[3] Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis [J].

Shimizu, T ;

Abe, R ;

Ohkawara, A ;

Nishihira, J .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (03) :659-664

[4] Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis [J].

Shimizu, T ;

Abe, R ;

Ohkawara, A ;

Mizue, Y ;

Nishihira, J .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 240 (01) :173-178

[5]

Yakuo Ikuhisa, 1994, Folia Pharmacologica Japonica, V103, P121, DOI 10.1254/fpj.103.121

← 1 →